Janux Therapeutics Inc’s recent filing unveils that its 10% Owner Avalon Ventures XI, L.P. acquired Company’s shares for reported $4.99 million on Nov 13 ’23. In the deal valued at $5.87 per share,849,854 shares were bought. As a result of this transaction, Avalon Ventures XI, L.P. now holds 849,854 shares worth roughly $41.38 million.
Then, Reardon Tighe bought 849,854 shares, generating $4,988,643 in total proceeds. Upon buying the shares at $5.87, the Acting Chief Financial Officer now owns 849,854 shares.
Before that, Lichter Jay bought 849,854 shares. Janux Therapeutics Inc shares valued at $4,988,643 were divested by the Director at a price of $5.87 per share. As a result of the transaction, Lichter Jay now holds 849,854 shares, worth roughly $41.38 million.
BTIG Research initiated its Janux Therapeutics Inc [JANX] rating to a Buy in a research note published on March 21, 2024; the price target was $62. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in mid March with a ‘”an Overweight”‘ rating. Wedbush began covering JANX with “an Outperform” recommendation on April 06, 2023. William Blair started covering the stock on November 14, 2022. It rated JANX as “an Outperform”.
Price Performance Review of JANX
On Friday, Janux Therapeutics Inc [NASDAQ:JANX] saw its stock fall -0.33% to $48.69. Over the last five days, the stock has lost -7.52%. Janux Therapeutics Inc shares have risen nearly 353.77% since the year began. Nevertheless, the stocks have risen 205.84% over the past one year. While a 52-week high of $58.69 was reached on 02/28/24, a 52-week low of $5.65 was recorded on 02/05/24. SMA at 50 days reached $34.63, while 200 days put it at $16.15. A total of 0.67 million shares were traded, compared to the trading of 0.4 million shares in the previous session.
Levels Of Support And Resistance For JANX Stock
The 24-hour chart illustrates a support level at 47.05, which if violated will result in even more drops to 45.41. On the upside, there is a resistance level at 49.73. A further resistance level may holdings at 50.77. The Relative Strength Index (RSI) on the 14-day chart is 66.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.46, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 35.03%. Stochastics %K at 64.09% indicates the stock is a holding.
